Dr reddys laboratories News: Dr reddys laboratories Latest News, Dr reddys laboratories Today news, Dr reddys laboratories Breaking News

An infographic comparing Nomura’s target prices for Dr. Reddy’s, Cipla, and Crompton Greaves, highlighting growth drivers like GLP-1 drug traction and ECD market expansion.

Cipla, Dr Reddy’s Lab, Crompton Greaves: Nomura’s top picks with 17% to 26% upside potential

Nomura sees up to 26% upside in Cipla, Dr Reddy’s Lab, and Crompton Greaves—discover why these stocks are top picks…

Updated: May 14, 2026 15:29 IST

HSBC India Underweight rating April 2026 stock market impact

Cipla to Sun Pharma: Nomura rates these 6 pharma stocks, riding the GLP-1 wave, ‘Buy’

The Indian Pharmaceutical Market (IPM) grew 10.1% year-on-year in March 2026, according to the report. Pricing contributed 5.5% to growth,…

Updated: April 15, 2026 15:21 IST

A technical stock market dashboard showing the FII long-short ratio at 16.8, with Sun Pharma and Tata Steel charts highlighting "Doji" and "Reversal" candlestick patterns near key support levels.

Monday Watchlist: Vedanta, Tata Steel, and 7 other stocks to watch – Small-caps show strength

Monday watchlist, April 05: Track Vedanta, Tata Steel, and top small-caps as technical trends signal possible short-term reversals—review market moves…

April 6, 2026 05:30 IST

₹1,000 cr to ₹5,000 cr: 3 pharma stocks to watch for India’s GLP-1 explosion by 2030

A ₹1,000 crore market is set to grow 5x to ₹5,000 crore by 2030 as prices drop 40–50% post patent…

March 31, 2026 05:27 IST

The brokerage believes semaglutide could become a meaningful growth driver for India’s pharma sector, but as more players enter and pricing pressure builds, execution, pricing strategy and distribution strength will determine long-term winners.

Alkem, Zydus Life: Nomura’s top picks to bet on Rs 12,000 crore generic Semaglutide opportunity

Nomura has a ‘Buy’ rating on Zydus Lifesciences, with the stock at Rs 891 and a target price of Rs…

March 23, 2026 14:55 IST

Dr Reddy’s launches ‘Obeda’ semaglutide injection

Dr Reddy’s on ‘Obeda’ launch: In step to democratize access to advanced therapy

Dr. Reddy’s Laboratories has launched ‘Obeda’, an injectable semaglutide therapy for diabetes and weight management in India.

March 21, 2026 21:09 IST

semaglutide india pharma stocks ozempic patent expiry

Sun Pharma to Cipla: 7 pharma stocks gear up for Rs 5,000 cr semaglutide opportunity after patent expiry

Ozempic patent expiry has triggered a fresh pharma race in India. Sun Pharma, Cipla, and Dr Reddy’s are among 7…

March 20, 2026 17:58 IST

Nippon India Small Cap Fund portfolio strategy returns MCX HDFC Bank

Nuvama ‘Overweight’ 8 stocks: Why Reliance, HDFC Bank, Infosys are top picks – Check full list

Nuvama turns selective in a risky market, backing Reliance, HDFC Bank and Infosys while flagging metals and autos as overvalued…

March 19, 2026 08:32 IST

India Inc promoters pump $4 billion into equities as valuations reach 10-year averages.

From Vodafone Idea, Dr Reddy’s Lab, DCX System, to Wipro – Here are 10 stocks to watch

Stocks to watch today, March 06: Discover key updates on Vodafone Idea, Wipro, Dr Reddy’s, and more—track the latest stock…

March 6, 2026 06:02 IST

Dr Reddy’s said the acquisition strengthens its gynaecology portfolio in India and marks its entry into the hormone replacement therapy segment.

Dr Reddy’s enters hormone therapy market with $32.15 million Progynova deal

The acquisition has been valued at $32.15 million (approximately Rs 295 crore), the company disclosed under Regulation 30 of Sebi’s…

February 19, 2026 11:18 IST

Brokerage consensus buy calls India Dr Reddy’s Zee Tata Communications Waaree Energies

Brokerage Consensus Stocks: 8 stocks draw ‘Buy’ calls across brokerages, with upside up to 90%

From pharma to media, eight Indian stocks earn ‘Buy’ calls from multiple brokerages, with upside potential touching 90%.

Updated: January 27, 2026 10:19 IST

stocks to watch today, market news December 1, Indian stock market updates

From Eternal, Waaree Energies to Jindal Stainless – Here are 10 stocks to watch

Track key stock moves as Indian firms release earnings and leadership updates—review complete financial highlights now!

January 22, 2026 06:30 IST

Budget 2026: From Cheaper Meds to 80D tax relief-Healthcare sector’s wish list for FM?

Discover 5 major healthcare changes expected in Budget 2026, including cheaper meds and new tax rules—see what industry experts recommend.

Updated: January 23, 2026 13:29 IST

Cipla Q3 results 2026, Cipla share price today, Nuvama on Cipla, Cipla target price cut

2026 & beyond: Indian pharma hinges hopes on innovation impetus & regulatory agility

The year 2025 has been a significant one for the Indian pharmaceutical sector. It witnessed several novel launches, collaborations, digital…

Updated: December 25, 2025 17:39 IST

From SAIL, JSW Energy to Paytm, Electronics – Here are 9 stocks to watch

Track key stock moves for SAIL, JSW Energy, Paytm, and more amid major corporate developments—explore today’s top market highlights.

December 15, 2025 06:30 IST

Nifty today, stock market outlook, Monday watchlist,

Monday Watchlist: TCS, Sun Pharma & 7 stocks to watch as Nifty pauses at record levels

Track TCS, Sun Pharma, and sector leaders as Nifty eyes higher targets; spot key stocks for your Monday investment moves…

December 1, 2025 05:30 IST

3 Defensive Bets to Consider for Your 2026 Portfolio

Explore 3 top defensive stocks for your 2026 portfolio to balance risk and stability—find out which companies to watch now!

Updated: December 4, 2025 12:36 IST

MCX Bharti Airtel Waaree Energies NTPC Green market movers India

From Bharti Airtel, BEL, Swiggy to Dr Reddy’s Lab – Here are 10 stocks to watch

Stocks to watch today, November 25: GIFT Nifty indicates a positive start for domestic indices. Here are the top stocks…

November 25, 2025 06:24 IST

Dr Reddy's Laboratories

Related News

Trending Topics